[HTML][HTML] Cost-minimization analysis in the treatment of spasticity in children with cerebral palsy with botulinum toxin type A: an observational, longitudinal, retrospective …

G Tapias, M García-Romero, C Crespo, M Cuesta… - Farmacia …, 2016 - Elsevier
Objective Cost-minimization analysis of onabotulinumtoxinA and abobotulinumtoxinA, taking
into account the real dose administered to children with spasticity associated with dynamic
equinus foot deformity due to cerebral palsy. Method A single centre, observational,
longitudinal, and retrospective study which included spastic paediatric patients aged 2-to-18-
years and treated with onabotulinumtoxinA or abobotulinumtoxinA from December 1995 to
October 2012, in the Paediatric Neurology Unit of a first-level Spanish hospital. A …
以上显示的是最相近的搜索结果。 查看全部搜索结果